amphetamine has been researched along with HIV Infections in 18 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Excerpt | Relevance | Reference |
---|---|---|
" Chronic use can cause cognitive impairment and other mental disorders, raising concerns about effects on retention and adherence with HIV care." | 1.46 | Frequent Use of Khat, an Amphetamine-Like Substance, as a Risk Factor for Poor Adherence and Lost to Follow-Up Among Patients New to HIV Care in Ethiopia. ( Ayana, DA; Bezabih, L; Dagne, B; Hilk, R; Lifson, AR; Melaku, Z; Shenie, T; Slater, L; Waktola, HT; Winters, KC; Workneh, S, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Perello, R | 1 |
Losada, A | 1 |
Chen Qin, J | 1 |
Supervia, A | 1 |
Salgado, E | 1 |
Smithson, A | 1 |
Xipell, M | 1 |
Inciarte, A | 1 |
Vallecillo, G | 1 |
Lifson, AR | 1 |
Workneh, S | 1 |
Shenie, T | 1 |
Ayana, DA | 1 |
Melaku, Z | 1 |
Bezabih, L | 1 |
Waktola, HT | 1 |
Dagne, B | 1 |
Hilk, R | 1 |
Winters, KC | 1 |
Slater, L | 1 |
Page, K | 1 |
Carrico, AW | 1 |
Stein, E | 1 |
Evans, J | 1 |
Sokunny, M | 1 |
Maly, P | 1 |
Sophal, C | 1 |
Neak, Y | 1 |
Ngak, S | 1 |
McCulloch, C | 1 |
Maher, L | 1 |
Li, Z | 1 |
Li, D | 1 |
Wang, N | 1 |
Hail-Jares, K | 1 |
Choi, S | 1 |
Duo, L | 1 |
Luo, Z | 1 |
Huang, ZJ | 1 |
Chao, C | 1 |
Jacobson, LP | 1 |
Tashkin, D | 1 |
Martínez-Maza, O | 1 |
Roth, MD | 1 |
Margolick, JB | 1 |
Chmiel, JS | 1 |
Holloway, MN | 1 |
Zhang, ZF | 1 |
Detels, R | 1 |
Talu, A | 1 |
Rajaleid, K | 1 |
Abel-Ollo, K | 1 |
Rüütel, K | 1 |
Rahu, M | 1 |
Rhodes, T | 1 |
Platt, L | 1 |
Bobrova, N | 1 |
Uusküla, A | 1 |
Ciccarone, D | 1 |
Bao, YP | 1 |
Liu, ZM | 1 |
Lian, Z | 1 |
Li, JH | 1 |
Zhang, RM | 1 |
Zhang, CB | 1 |
Hao, W | 1 |
Wang, XY | 1 |
Zhao, M | 1 |
Jiang, HF | 1 |
Yan, SY | 1 |
Wang, QL | 1 |
Qu, Z | 1 |
Zhang, HR | 1 |
Wu, P | 1 |
Shi, J | 1 |
Lu, L | 1 |
Rajs, J | 1 |
Petersson, A | 1 |
Thiblin, I | 1 |
Olsson-Mortlock, C | 1 |
Fredriksson, A | 1 |
Eksborg, S | 1 |
Peretti-Watel, P | 1 |
Spire, B | 1 |
Lert, F | 1 |
Obadia, Y | 1 |
Schütz, CG | 1 |
Rapiti, E | 1 |
Vlahov, D | 1 |
Anthony, JC | 1 |
Darke, S | 2 |
Ross, J | 1 |
Cohen, J | 1 |
Käll, K | 1 |
Hando, J | 1 |
Hall, W | 2 |
Ross, M | 1 |
Wodak, A | 1 |
Klee, H | 2 |
Morris, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence[NCT01369056] | 150 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for amphetamine and HIV Infections
Article | Year |
---|---|
Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine; Cocaine-Rela | 2011 |
A new target for behavioural research--amphetamine misuse.
Topics: Amphetamine; Heroin Dependence; HIV Infections; Humans; Illicit Drugs; Needle Sharing; Risk Factors; | 1992 |
1 trial available for amphetamine and HIV Infections
Article | Year |
---|---|
Cluster randomized stepped-wedge trial of a multi-level HIV prevention intervention to decrease amphetamine-type stimulants and sexual risk in Cambodian female entertainment and sex workers.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Asian People; Central Nervous System Stimulants; | 2019 |
15 other studies available for amphetamine and HIV Infections
Article | Year |
---|---|
Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
Topics: Adult; Amphetamine; Consciousness Disorders; Emergency Service, Hospital; HIV Infections; Humans; Ma | 2023 |
Frequent Use of Khat, an Amphetamine-Like Substance, as a Risk Factor for Poor Adherence and Lost to Follow-Up Among Patients New to HIV Care in Ethiopia.
Topics: Adult; Amphetamine; Catha; Ethiopia; Female; HIV Infections; Humans; Lost to Follow-Up; Male; Patien | 2017 |
[Progress of research on amphetamine-type stimulants abuse and associated HIV/STD risks among female drug users].
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Drug Users; Female; HIV Infections; Hu | 2015 |
Occupational and demographic factors associated with drug use among female sex workers at the China-Myanmar border.
Topics: Adolescent; Adult; Amphetamine; China; Demography; Female; HIV Infections; Humans; Myanmar; Risk-Tak | 2016 |
Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Cohort Studies; HIV Infections; Humans; Illicit D | 2009 |
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Topics: Adult; Amphetamine; Cross-Sectional Studies; Drug Overdose; Estonia; Female; Fentanyl; HIV Infection | 2010 |
Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China.
Topics: Adolescent; Adult; Aged; Amphetamine; China; Coinfection; Cross-Sectional Studies; Female; Hepatitis | 2012 |
Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal study.
Topics: Adolescent; Adult; Age Distribution; Amphetamine; Body Mass Index; Cannabis; Cocaine; Dopamine Uptak | 2004 |
Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).
Topics: Adult; Amphetamine; Antiretroviral Therapy, Highly Active; Cluster Analysis; Cocaine-Related Disorde | 2006 |
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
Topics: Adolescent; Adult; Amphetamine; Baltimore; Cocaine; Cross-Sectional Studies; Female; Follow-Up Studi | 1994 |
The use of benzodiazepines among regular amphetamine users.
Topics: Adolescent; Adult; Amphetamine; Anti-Anxiety Agents; Benzodiazepines; Comorbidity; Female; HIV Infec | 1994 |
The risk of HIV infection for noninjecting sex partners of injecting drug users in Stockholm.
Topics: Adult; Amphetamine; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV Infections | 1994 |
HIV risk-taking behaviour among amphetamine users in Sydney, Australia.
Topics: Adult; Amphetamine; Female; HIV Infections; Humans; Male; Needle Sharing; New South Wales; Risk-Taki | 1994 |
Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia.
Topics: Adolescent; Adult; Amphetamine; Cross-Sectional Studies; Female; HIV Infections; Humans; Incidence; | 1993 |
The role of needle exchanges in modifying sharing behaviour: cross-study comparisons 1989-1993.
Topics: Adult; Amphetamine; England; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV I | 1995 |